Skip to main content
Novartis Top Menu
  • Novartis.com
Novartis Foundation LOGO
User account menu
  • Search
  • Menu
  • About Us
    • Board of Trustees
      • Joerg Reinhardt, Ph.D.
      • Ann Aerts, M.D.
      • Dr. Jo Ivey Boufford
      • Lutz Hegemann, M.D., Ph.D.
      • Prof. Peter Piot, M.D.
    • Our Team
      • Johannes Boch
      • Cristina Haffner
      • Jason Shellaby
      • Lucy Setian
      • Sarah Des Rosiers
      • Xavier Sutter
    • Our partners
    About Us
  • Transforming population health
    • Cardiovascular population health initiative
    • AI4BetterHearts
    • AI in health policy
      • Broadband Commission Working Group on Digital and AI in Health
      • HealthTech Dialogue Hub
    • HealthTech Innovation
      • Brazil COVID-19 response
      • AI4Leprosy
    Transforming Population Health
  • Urban Population Health Toolkit
    • Quality of care
    • Ensure access
    • Policy reform
    • Leverage data and digital
    • Intersectoral collaboration
    • Ensure local ownership
    Urban Population Health Toolkit
  • Past programs
    • Better Hearts Better Cities
      • Community-based Hypertension Improvement Project (ComHIP)
      • Communities for Healthy Hearts
      • KaziBantu (Healthy Schools for Healthy Communities)
    • Leprosy and malaria elimination
      • The Leprosy Alert and Response Network System (LEARNS)
      • Leprosy Post-Exposure Prophylaxis (LPEP) program
      • Malaria Targeted Parasite Elimination Strategy
    • Digital Health
      • Ghana Telemedicine
      • Telemedicine Toolkit
      • Integrated e-Diagnostic Approach
    Past Programs
  • Media Center
    • News Archive
    • Media Library
    • Stories
    Media Center
Homepage
Date range
  1. Home
  2. Media Center
  3. Media Library

Role of Contact Tracing and Prevention Strategies in the Interruption of Leprosy Transmission

Back to Previous Page

The global prevalence of leprosy has declined from 5.2 million in the 1980 s to 200,000 today. The article outlines how contact tracing and chemoprophylaxis programmes can be implemented to interrupt leprosy transmission.

Role of Contact Tracing and Prevention Strategies in the Interruption of Leprosy Transmission (PDF 127.45 KB)

Related Items

  • Document
    Leprosy, Publication
    Leprosy Post-exposure Prophylaxis with Single-dose Rifampicin (LPEP): An International Feasibility Programme
  • Document
    Leprosy, Publication
    Leprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User’s Perspective
  • Document
    Leprosy, Publication
    An Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia
Navigate Novartis Foundation
  • About Us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs
About the Novartis Foundation
  • Board of Trustees
  • Our Partners
  • Our Team
Media Center
  • News Archive
  • Media Library
  • Our Stories
Footer Bottom
© 2021 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for a global audience